Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2
暂无分享,去创建一个
Kevin W Eliceiri | Patricia J Keely | Andriy Marusyk | K. Eliceiri | A. Tan | P. Keely | A. Marusyk | V. Borges | T. Lyons | M. Conklin | P. Schedin | Aik-Choon Tan | Matthew W Conklin | Traci R Lyons | Pepper Schedin | Virginia F Borges | Jenean O'Brien | J. O'Brien | A. Tan
[1] I. Fentiman,et al. Inflammation and breast cancer , 2013 .
[2] Paolo P. Provenzano,et al. Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma Address Reprint Requests to See Related Commentary on Page 966 , 2022 .
[3] Charles M Perou,et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Donna Spiegelman,et al. Aspirin intake and survival after breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] V. Borges,et al. Epithelial and Mesenchymal Cell Biology Alternatively Activated Macrophages and Collagen Remodeling Characterize the Postpartum Involuting Mammary Gland across Species , 2010 .
[6] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[7] B. Hamilton,et al. Delayed childbearing: more women are having their first child later in life. , 2009, NCHS data brief.
[8] W. Gerald,et al. Genes that mediate breast cancer metastasis to the brain , 2009, Nature.
[9] V. Borges,et al. Pregnancy and Breast Cancer: when They Collide , 2009, Journal of Mammary Gland Biology and Neoplasia.
[10] Valerie M. Weaver,et al. A tense situation: forcing tumour progression , 2009, Nature Reviews Cancer.
[11] S. Fosså,et al. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Ana M Soto,et al. A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. , 2008, Tissue engineering. Part C, Methods.
[13] Matthias Schäfer,et al. Cancer as an overhealing wound: an old hypothesis revisited , 2008, Nature Reviews Molecular Cell Biology.
[14] G. Xing,et al. Evidence of Poorer Survival in Pregnancy-Associated Breast Cancer , 2008, Obstetrics and gynecology.
[15] B. Strom,et al. Breast Cancer Risk and Hormone Receptor Status in Older Women by Parity, Age of First Birth, and Breastfeeding: A Case-Control Study , 2008, Cancer Epidemiology Biomarkers & Prevention.
[16] Jun Yao,et al. Regulation of in situ to invasive breast carcinoma transition. , 2008, Cancer cell.
[17] K. Joseph,et al. Relationship of Time Since Childbirth and Other Pregnancy Factors to Premenopausal Breast Cancer Prognosis , 2008, Obstetrics and gynecology.
[18] C. Rueden,et al. Bmc Medicine Collagen Density Promotes Mammary Tumor Initiation and Progression , 2022 .
[19] R. Vierkant,et al. Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. , 2008, Journal of the National Cancer Institute.
[20] Charles M. Perou,et al. Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution , 2008, Clinical Cancer Research.
[21] Karla Kerlikowske,et al. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. , 2007, Cancer cell.
[22] Louise R Howe,et al. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer , 2007, Breast Cancer Research.
[23] G. Ayers,et al. COX-2 involvement in breast cancer metastasis to bone , 2007, Oncogene.
[24] L. Habel,et al. NSAIDs and breast cancer recurrence in a prospective cohort study , 2007, Cancer Causes & Control.
[25] R. Weinberg,et al. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. , 2007, Cancer research.
[26] C. Liang,et al. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro , 2007, Nature Protocols.
[27] Paolo P. Provenzano,et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion , 2006, BMC medicine.
[28] A. Sjölander,et al. α2β1 integrin signalling enhances cyclooxygenase‐2 expression in intestinal epithelial cells , 2006, Journal of cellular physiology.
[29] Shailesh Singh,et al. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression , 2006, BMC Cancer.
[30] P. Schedin. Pregnancy-associated breast cancer and metastasis , 2006, Nature Reviews Cancer.
[31] Meenakshi Singh,et al. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. , 2006, The American journal of pathology.
[32] R. Cardiff,et al. HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. , 2005, Cancer research.
[33] Cynthia A. Reinhart-King,et al. Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.
[34] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[35] M. Backlund,et al. Mechanisms of Disease: inflammatory mediators and cancer prevention , 2005, Nature Clinical Practice Oncology.
[36] Howard Y. Chang,et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Schedin,et al. Mammary ECM composition and function are altered by reproductive state , 2004, Molecular carcinogenesis.
[38] V. Bergdall,et al. The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing. , 2004, The American journal of pathology.
[39] P. Wingo,et al. Reproductive History and Mortality After Breast Cancer Diagnosis , 2004, Obstetrics and gynecology.
[40] M. Burns,et al. Case-Control Study , 2020, Definitions.
[41] Joanna S Morris,et al. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3 , 2003, Breast Cancer Research.
[42] Tom Freeman,et al. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression , 2003, Breast Cancer Research.
[43] H. Anderson,et al. Worse survival in breast cancer among women with recent childbirth: results from a Swedish population-based register study. , 2003, Clinical breast cancer.
[44] W. Weichert,et al. Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma , 2003, Cancer.
[45] M. Steurer,et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival , 2003, British Journal of Cancer.
[46] J. Zavadil,et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. , 2002, Cancer research.
[47] C. Hudis,et al. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. , 2002, Cancer research.
[48] P. Porter,et al. The relation of reproductive factors to mortality from breast cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[49] J. Isola,et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. , 2002, Cancer research.
[50] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[51] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[52] T. Hla,et al. Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[53] F. Miller,et al. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. , 2000, Journal of the National Cancer Institute.
[54] P. Schedin,et al. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. , 2000, Cancer research.
[55] K. Sheahan,et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. , 1999, JAMA.
[56] C. Paraskeva,et al. COX-2 inhibitors for colorectal cancer , 1998, Nature Medicine.
[57] M. O'neill,et al. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis , 1996, International journal of cancer.
[58] H. Adami,et al. Transient increase in the risk of breast cancer after giving birth. , 1994, The New England journal of medicine.
[59] M. Thun,et al. Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.
[60] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.